Rationale and design of a placebo-controlled trial to evaluate the steroid-sparing effects of anti-IL5 monoclonal antibody (mepolizumab): Focus on cutaneous outcomes in patients with hypereosinophilic syndrome (HES)
Document type:
Meeting Abstract
Author(s):
Shear, N; Gleich, G; Leiferman, K; Ring, J
Journal title abbreviation:
J Am Acad Dermatol
Year:
2007
Journal volume:
56 Suppl.
Journal issue:
2
Pages contribution:
AB71-AB71
Language:
eng
Print-ISSN:
0190-9622
TUM Institution:
Klinik und Poliklinik für Dermatologie und Allergologie